Commerce issues AD and CVD orders on L-lysine from China
L-lysine From the People's Republic of China: Antidumping Duty Order and Countervailing Duty Order
Commerce is issuing antidumping and countervailing duty orders on L-lysine from the People's Republic of China, applicable September 16, 2026, based on affirmative final determinations by Commerce and the U.S. International Trade Commission. Commerce found Inner Mongolia Eppen to be cross-owned with Heilongjiang Eppen Trading Co., Ltd.; Heilongjiang Eppen Biotech Co., Ltd.; Heilongjiang Eppen Energy Co.; Ningxia Eppen Biotech Co. Ltd.; Star Lake Bioscience Co., Ltd Zhaoqing Guangdong; and Guangdong Guangxin Holdings Group Ltd. The orders follow the final AD determination at 91 FR 46406 and the final CVD determination at 91 FR 46399, both published July 23, 2026, and the ITC's final determination at 91 FR 57162.
Entries of L-lysine from China are subject to the AD and CVD orders as of September 16, 2026, with the cross-owned companies listed under Inner Mongolia Eppen covered by the same case.
Source: Federal Register · Commerce ITA (AD/CVD) · federalregister.gov